S4 Fig -

S4 Fig -

<p>Incidence and Prevalence of (A) thyroid, (B) bisphosphonates, and (C) antiviral use in Manitoba from Q3-2016 until Q1-2021.</p> <p>(TIF)</p>

Saved in:

Bibliographic Details
Main Author:	Laila Aboulatta (11531371) (author)
Other Authors:	Payam Peymani (12433284) (author), Christine Vaccaro (10896319) (author), Christine Leong (6429392) (author), Kaarina Kowalec (10153508) (author), Joseph Delaney (3624080) (author), Jamie Falk (6429398) (author), Silvia Alessi-Severini (413098) (author), Basma Aloud (11531374) (author), Sherif Eltonsy (6913289) (author)
Published:	2022
Subjects:	Medicine Biotechnology Evolutionary Biology Ecology Developmental Biology Infectious Diseases Computational Biology two time periods subclass analysis showed limited evidence exists canadian provincial governments administrative health databases take unprecedented measures increased health services 83 %, 23 67 %), hypertension pandemic restrictions resulted monitor prescription trends drug utilization patterns antibiotic prevalent users significant slope increase level among nsaids prescription trends prevalent users including restrictions healthcare services 64 %), 05 %, prevalent use 19 pandemic 19 measures significant impact significant decrease drugs among 19 among xlink "> wide cross sectional study relative decline quarterly cardiovascular march 2021 march 2020 july 2016 findings show common comorbidities cardiovascular drugs better understand april 2020 aggregated utilization 630 manitobans 31 %).
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!